Inositol for Insulin Resistance: Evidence and Label Comparisons
Compare inositol formulas and routines while distinguishing metabolic research from clinical assessment and unsupported brand claims for insulin resistance.
by Eco Hormone Balance Editorial Team · Published March 11, 2026 · Evidence & product details rechecked October 12, 2026

Contents
- Assessment comes before comparing bottles
- Why these two products are included
- Metabolic measurements are not a brand ranking
- Ovasitol: powder with two daily servings
- Wholesome Story: two inositols without added active nutrients
- Before using a retailer link
- What the clinical evidence can establish
- Product labels to compare
Inositol has been studied in PCOS metabolic research, but product labels cannot establish treatment of insulin resistance. Compare documented ingredients without substituting a supplement for medical assessment.
Assessment comes before comparing bottles
The international PCOS guideline recommends assessment of glycaemic status at diagnosis. It identifies the oral glucose tolerance test as the most accurate option in PCOS and notes that routine insulin assays have limited clinical relevance. Ask your clinician which assessment fits your circumstances; do not use a supplement response or a research insulin marker as a self-diagnosis.
Read the guideline’s glycaemic assessment recommendations.
Why these two products are included
The examples below have documented plain inositol formulas and illustrate powder versus capsules. They are not an exhaustive shortlist or a ranking by glucose-lowering effect. A shared ingredient ratio does not make daily instructions, pack duration or delivered cost identical.
| Practical criterion | Ovasitol original canister | Wholesome Story 120 capsules |
|---|---|---|
| Format | Measured powder | Capsules |
| Labelled serving | One scoop | Four capsules |
| Manufacturer daily routine | Two servings | One or two servings |
| Pack duration under those routines | 90 days | 15–30 days |
| What this cannot compare | Individual glucose response | Individual glucose response |
Use these differences to compare convenience after the clinical decision. Do not double a capsule routine simply to match a powder’s daily amount or replace a prescribed medicine because the formula looks similar.
Metabolic measurements are not a brand ranking
Changes in insulin or glucose measurements in a study need interpretation alongside its design, participants and comparison group. They do not establish prevention of diabetes or show that a particular bottle will work for you.
If you use glucose-lowering medication, discuss the exact supplement and intended amount with your clinician or pharmacist. Keep prescribed treatment and any agreed monitoring plan in place unless your prescriber changes them.
Ovasitol: powder with two daily servings
The compared canister contains 180 servings. Each supplies 2,000 mg myo-inositol and 50 mg D-chiro-inositol; the manufacturer directs two servings daily, making a 90-day canister. Only the two inositols are listed. The manufacturer names NSF contents certification, which concerns product quality rather than fertility efficacy.
Wholesome Story: two inositols without added active nutrients
The 120-capsule pack has 30 four-capsule servings. Each serving contains 2,000 mg myo-inositol and 50 mg D-chiro-inositol. Manufacturer instructions allow one or two servings daily, so that pack lasts 15–30 days. Check which routine your clinician has agreed with you; do not assume every four-capsule bottle lasts the same time.
Before using a retailer link
Read the full label, including additional nutrients and daily instructions. Check for overlap with your current supplements and take the label to your clinician if you are pregnant, trying to conceive or taking medicines. A manufacturer’s serving is a product description, not a personalised dose.
What the clinical evidence can establish
The 2023 international PCOS guideline describes limited clinical benefits from inositol and insufficient evidence to recommend a particular type, dose or combination. A 40:1 label is a formulation detail, not a clinical endorsement or proof that one brand works better.
Read the international PCOS guideline.
Product labels to compare
These reviews compare published ingredients and routines. Their inclusion does not establish that a product treats the symptoms discussed above. Check the exact bottle, market and formulation before using a retailer link.
Compare dated prices and equivalent ingredient amounts in the main buying guide.
How we research this guide
This educational guide uses published research and clinical guidance. Where products are discussed, we also check their labels and publicly available manufacturer information. We distinguish study findings from established clinical benefits.
Evidence can change, and a guide cannot determine which treatment or supplement is suitable for an individual. Affiliate commissions do not determine our conclusions.
Guide content reviewed October 12, 2026.
What to read next
Finish your research with the guides that explain the formula, then compare the leading products before you commit.
References
- International evidence-based PCOS guideline (2023): inositol and infertility recommendations
- Inositol for PCOS: systematic review informing the guideline (2024)
- Theralogix Ovasitol Inositol Powder: manufacturer product information
- Wholesome Story Myo-Inositol & D-Chiro Inositol (40:1): manufacturer product information
- Fairhaven Health Myo + D-Chiro Inositol: manufacturer product information
- International PCOS guideline
- NCCIH: diabetes and dietary supplements
Frequently Asked Questions
Does a 40:1 ratio prove this product works for this goal?
No. A ratio describes relative amounts; it does not establish efficacy for a symptom or show that a brand performs better than another.
How should I compare products if I decide to use inositol?
Compare exact ingredient amounts, added nutrients, labelled daily instructions, pack duration and dated cost. Keep the clinical decision separate from the purchase comparison.
Can a supplement response diagnose insulin resistance?
No. Product response and research markers do not replace clinical assessment. Ask your clinician which glucose assessment and follow-up are appropriate.